Novel synthetic studies of heterocycles containing nitrogen by reductive ring expansion of oximes and their application to synthesis of candidate compounds for clinical studies.
| Project/Area Number |
23590001
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Chemical pharmacy
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
CHO HIDETSURA 東北大学, 薬学研究科(研究院), 客員教授 (40511910)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2013: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | 水素化ジイソブチルアルミナム(DIBALH) / 水素化ジクロロアルミニウム(AlHCl2) / DIBALHによる還元的環拡大反応 / オキシムの転位反応 / ヒドロキシルアミン / AVP antagonist / 17 beta-HSD3 inhibitor / URAT-1 inhibitor / 転位反応 / 含窒素複素環化合物 / オキシム / 17-beta HSD inhibitor / 17-beta HSD 3 inhibitor |
|---|
| Research Abstract |
The reductive rearrangement of various cyclic and acyclic oximes with aluminum reductants (DIBALH, AlHCl2 etc.) was performed to afford various secondary amines. This reaction regioselectively afforded a variety of five- to eight-membered bicyclic heterocycles or tricyclic heterocycles containing nitrogen neighboring an aromatic ring.
The reaction proceeds through a three-centered transition state via a stepwise mechanism, because the potential energy curve along the intrinsic reaction coordinate had two maxima and the partial phenonium cation intermediate. The preference of the migration of a substituent was clarified that the more electron-rich group migrated preferentially to give the corresponding compounds. Their application to synthetic studies of several candidate compounds (AVP antagonist, 17 beta-HSD inhibitor, URAT-1 inhibitor) for clinical studies was demonstrated. Therefore, this reaction could be of practical use for the synthesis of fine chemistry and medicinal chemistry.
|
Report
(4 results)
Research Products
(30 results)
